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Objective: Laparoscopic surgery is currently the gold standard for benign ovarian tumors because of its
overall improved quality of life. However, some tumors diagnosed preoperatively as benign may be
proven to be malignant by postoperative studies. The standard approach for the removal of a malignant
ovarian tumor in our hospital is via laparotomy; however, at present there are no referential prognostic
data on malignancies that were excised laparoscopically. This study retrospectively reviewed cases in our
hospital that underwent surgery based on the preoperative diagnosis of benignancy but postoperatively
proved to be borderline or malignant to evaluate clinical and histological factors as well as prognosis.
Patients and methods: The study group was comprised of 1322 women who underwent a laparoscopic
procedure on the basis of a preoperative diagnosis of a benign ovarian tumor in our hospital between
1995 and 2011. The rate of borderline and malignant cases, histology, and postoperative treatment were
investigated.
Results: Of the 1322 cases, 15 (1.1%) were postoperatively diagnosed as a borderline malignancy with
varied histological types and all had a good prognosis; four (0.3%) were postoperatively diagnosed as
malignant with varied histological types among which two required emergency surgery. All four cases
underwent additional surgery and chemotherapy with no recurrence to date.
Discussion: Some cases diagnosed preoperatively as benign proved postoperatively to be malignant.
Appropriate postoperative treatment was effective in improving the prognosis. Particular attention
should be paid to a possible occult malignancy that may manifest postoperatively, especially in cases of
emergency surgery. We recommend preoperative magnetic resonance imaging even for emergency cases
to improve preoperative diagnosis.
Copyright © 2015, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.PL
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An ovarian tumor is one of the most common gynecological
tumors. Currently, laparoscopic surgery is the gold standard for
benign ovarian tumors because of its overall improved quality of
life.1 It has been reported that 70.1% of ovarian tumors preopera-
tively diagnosed as benign are laparoscopically excised in Japan.2D
Uinterest in this study.
ics and Gynecology, Kinki
ashi, Osaka-sayama, Osaka,
Y. Kotani).
for Gynecologic Endoscopy and MinimHowever, 0.4% of tumors diagnosed preoperatively as benign are
proven postoperatively to be malignant. In these cases, intra-
operative cyst rupture can be a great risk with laparoscopic surgery.
Intraoperative cyst rupture may cause upstaging, and some cases
require additional treatment or chemotherapy postoperatively.
Laparoscopic surgery is more likely to cause cyst rupture than open
surgery.3 These malignant cases essentially undergo a standard
laparotomy; however, at present there is no referential data
regarding either the prognosis or the consensus to indicate lapa-
roscopy unconditionally for early-stage ovarian cancer.
This study retrospectively reviewed cases involving women in
our hospital who underwent surgery based on a preoperative
diagnosis of a benign tumor that postoperatively proved to be
borderlinemalignant or malignant. By investigating these cases, weally Invasive Therapy. Published by Elsevier Taiwan LLC. All rights reserved.
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histological ﬁndings.
Patients and methods
The study groupwas comprised of 1322womenwho underwent
a laparoscopic procedure in our hospital for an ovarian tumor that
was preoperatively diagnosed as benign between January 1995 and
December 2011 (1089 cases of ovarian tumorectomy and 233 cases
of adnexectomy).
The rate of borderline malignant and malignant cases among
them was based on postoperative pathology. The following data
were reviewed: patient age, tumor size, surgical procedure, histo-
logical type, incidence of cyst rupture, and postoperative treatment.
The patients were classiﬁed into three groups based on the post-
operative pathologic diagnosis: benign, borderline malignant, and
malignant. Preoperative mean patient age and mean largest tumor
diameter were compared among the groups.
The preoperative diagnosis in our institution was based on ul-
trasound, computed tomography (CT), and magnetic resonance
imaging (MRI) images. The solid portion of the tumor and the wall
thickness were evaluated to differentiate between benignancy and
malignancy.4 (However, some emergent cases underwent surgery
after CT and/or ultrasound examination only.) On the basis of the
preoperative diagnosis, we selected laparoscopy for benignancy
and open surgery for malignancy and cases for which malignancy
could not be ruled out.
In our department, laparoscopy is performed by ﬁrst attaining
pneumoperitoneum through the umbilicus using a closed method.
Three 5-mm trocars are inserted at: the umbilicus, the midline of
the lower abdomen, and the right side of the lower abdomen; one
12-mm trocar is inserted in the left lower abdomen. Adnexectomy
is performed by doubly ligating the suspensory ovarian ligament
followed by the coagulation and dissection of the fallopian tube and
ovarian ligament; the adnexa is then excised. Ovarian tumorectomy
is performed by making an incision halfway around the tumor
along the equatorial line, starting from the opposite side of the
ovarian hilum; the tumor is carefully dissected to avoid cyst
rupture. After aspirating the contents into the pouch of an Endo
Catch Gold, which is inserted through the 12 mm trocar, the tumor
is then transferred out of the abdomen.
For statistical analysis, the ManneWhitney U test was used to
compare the mean values between the two groups. A p value < 0.05
was considered statistically signiﬁcant.Table 1
Patient age, tumor size, procedure, result, and follow-up of the postoperative borderline
Case No. Age at surgery (y) Tumor diameter
(cm)
Procedure C
1 30 4.5 LC* P
2 30 7 LC P
3 47 5 LC N
4 28 8 LC P
5 36 4 LC P
6 43 6 LC P
7 30 8 LC P
8 35 6 LC P
9 26 8 LC N
10 79 6 LA N
11 51 5 LA N
12 34 7 LC P
13 32 8 LC P
14 36 2 LC N
15 38 5 LC P
Mean 38.3 6.0
BM ¼ borderline malignancy; LA ¼ laparoscopic adnexectomy; LC ¼ laparoscopic cystec
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Of the 1322 cases, the number of cases postoperatively diag-
nosed as borderline malignancy was 15 (1.1%). There were four
cases postoperatively diagnosed as malignant (0.3%). Table 1
summarizes the patient age, tumor size, surgical procedure, his-
tological type, incidence of cyst rupture, and postoperative treat-
ment regarding the cases postoperatively diagnosed as borderline
malignant. The mean patient age was 38.3 years and the mean
largest tumor size was 6.0 cm. Laparoscopic adnexectomy was
performed for two menopausal women; laparoscopic ovarian
tumorectomy was performed for the other 13 women who were
premenopausal. Cyst rupture occurred in 10 of 15 cases. Histolog-
ical types were serous cystadenoma (4 cases), mucinous cys-
tadenoma (4 cases), immature teratoma G1 (4 cases), granulosa cell
tumor (2 cases), and endometrial cyst (1 case). A subsequent
adnexectomy was performed in four cases. To date, recurrence has
been conﬁrmed in only one case. This patient developed ipsilateral
ovarian tumors 1 year and 3 years postoperatively. She was un-
dergoing infertility treatment and an ovarian tumorectomy was
performed for both recurrences. The conservative procedures were
performed in accordance with her desire to preserve her fertility.
She gave informed consent. The histological type was the same for
all the three surgeries: mucinous cystadenoma, which is a
borderlinemalignancy. At present, 3 years after her last surgery, she
has not experienced a recurrence.
Table 2 summarizes the preoperative patient age, tumor size,
surgical procedure, histological type, incidence of cyst rupture, and
postoperative treatment regarding the cases postoperatively diag-
nosed as malignant. The mean patient age was 33.8 years and the
mean largest tumor size was 8.5 cm (Table 3). Laparoscopic ovarian
tumorectomy was performed for all the cases. Cyst rupture
occurred in one case and the cyst had already naturally ruptured
preoperatively (voluntary rupture) in two of the four cases. Histo-
logical types were one case each of serous cystadenocarcinoma,
mucinous cystadenocarcinoma, yolk sac tumor, and squamous cell
carcinoma (malignant transformation from a mature cystic tera-
toma). The serous cystadenocarcinoma case was complicated by
tumor torsion and cyst rupture; the squamous cell carcinoma case
was complicated by cyst rupture. Both cases required emergency
surgery. Therefore, in these cases, only a CT scan was performed
preoperatively; MRI was omitted to save time. The yolk sac tumor
case was ﬁrst diagnosed as a mature cystic teratoma due to the
imaging of fat within the tumor by MRI; however, the ﬁnal
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resent Granulosa cell tumor LA
one Immature teratoma G1
resent Immature teratoma G1
resent Granulosa cell tumor
resent Mucinous cyst adnoma (BM) LA
resent Mucinous cyst adnoma (BM) LC at 2 recurrences
resent Endometrial cyst (BM)
one Immature teratoma G1 LA
one Serous cyst adenoma (BM)
one Mucinous cyst adnoma (BM)
resent Serous cyst adenoma (BM)
resent Mucinous cyst adenoma (BM) LA
one Immature teratoma G1
resent Serous cyst adenoma (BM)
tomy.
Table 2
Patient age, tumor size, procedure, result, and follow-up of the postoperative malignancy cases.
Case No. Age at
surgery (y)
Tumor
diameter (cm)
Procedure Cyst rupture Histology Postoperative treatment
1 36 8 LC Voluntary Serous cyst adenocarcinoma Standard surgery for ovarian cancera/TC
2 19 10 LC None Yolk sac tumor Adnexectomy/biopsy of the healthy side/omentectomy/BEP
3 42 9 LC Present Mucinous cyst adenocarcinoma Standard surgery for ovarian cancer/TC
4 38 7 LC Voluntary Squamous cell carcinoma Standard surgery for ovarian cancer/TC
Mean 33.8 8.5
BEP ¼ bleomycin, etoposide, and a platinum agent (e.g., cisplatin); LC ¼ laparoscopic cystectomy; TC ¼ taxotere and cyclophosphamide.
a Standard surgery for ovarian cancer: Abdominal total hysterectomy, bilateral adnexectomy, retroperitoneal lymph node dissection, and omentectomy.
Table 3
Mean patient age and mean largest tumor diameter by group.
Benignancy
n ¼ 1303
Borderline
n ¼ 15
Malignancy
n ¼ 4
Age (y) 36.5 ± 12.9
(7e93)
38.3 ± 13.3
(26e79)
33.8 ± 10.1
(19e42)
Tumor diameter (cm) 6.2 ± 2.6
(1e20)
6.0 ± 1.8
(2e8)
8.5 ± 1.3*
(7e10)
Data are presented as mean ± SD (range).
SD ¼ standard deviation.
* A signiﬁcant difference was conﬁrmed in the mean largest tumor diameter be-
tween the malignant tumors and the other two groups, p < 0.05.
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surgery and chemotherapy with no recurrences to date.
On the basis of the postoperative pathology, the cases were
classiﬁed into three groups: benign, borderline malignancy, and
malignancy. The mean patient age and mean largest tumor diam-
eter were compared among the groups. No signiﬁcant difference
was found in the mean preoperative age between benignancy (36.5
years; 1303 cases), borderline malignancy (38.3 years; 15 cases),
and malignancy (33.8 years; 4 cases). A signiﬁcant difference was
conﬁrmed in the mean largest tumor diameter between the ma-
lignant tumors and the other two groups: malignant, 8.5 cm;
benign, 6.2 cm; borderline, 6.0 cm.
Discussion
Various factors should be considered when laparoscopic surgery
is performed for a preoperatively diagnosed benign ovarian tumor
that proves to be malignant or borderline postoperatively: (1)
upstaging by intraoperative cyst rupture; (2) challenge in obtaining
accurate staging due to an insufﬁcient sample collected; (3)
possible delay in primary treatment; (4) metastases/recurrence at
the trocar inserting site; and (5) growth/development of tumor
cells triggered by pneumonia. Regarding the prognostic factor with
cyst rupture, Canis et al5 stated that intraoperative cyst rupture is
an important prognostic factor for stage I ovarian cancer; further-
more, the laparoscopic puncture of malignant ovarian tumors
conﬁned to the ovaries is uncommon and should be avoided
whenever possible. Vergote et al6 reported that cyst rupture before
or during surgery decreases disease-free survival and should be
avoided in patients with a possible diagnosis of ovarian carcinoma
conﬁned to the ovaries. However, Ahmed et al7 reported that
intraoperative rupture was not a prognostic factor. Currently, the
possible negative impact of intraoperative cyst rupture on the
prognosis of early-stage ovarian cancer is controversial.8
Regarding borderline malignancy, 10-year survival rate for stage
I is 97%, indicating a better prognosis compared with malignant
cases. Some investigators have reported that the prognosis was the
same in stage IC even if the standard open surgery for ovarian
cancer was not subsequently performed.9e11 The prognoses of our
cases were good evenwithout additional surgery or chemotherapy.
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benignancy by preoperative MRI. We also employ the utmost effort
to avoid intraoperative cyst rupture in all cases. However, this study
revealed that 1.1% of the preoperatively diagnosed benign cases
were in fact borderline and 0.3% malignant. Two malignant cases
required emergency surgery, whichmeans preoperative ultrasound
or CT was not sufﬁcient to detect the solid portion of the tumor
because of their inferior imaging quality compared to a MRI.4 Even
a small solid area can possibly be malignant.4 Therefore, in emer-
gency surgery, particular attention should be paid to a possible
occult malignancy that may be revealed postoperatively.
Regarding cyst rupture during ovarian tumorectomy, Shiota
et al3 reported that the rate was signiﬁcantly higher in laparoscopy
than in laparotomy. Conversely, cyst rupture rate during adnex-
ectomy is comparable between laparoscopy and laparotomy for
tumor < 10 cm; however, for tumors  10 cm laparoscopy was
reported to have a signiﬁcantly higher cyst rupture rate than lap-
arotomy.3 In our hospital, although we try our best to avoid cyst
rupture, it cannot always be circumvented because of individual
case characteristics. All malignant tumors in this study were <
10 cm and the mean largest diameter was signiﬁcantly larger than
that of the benign masses. Increased risk of malignancy is reported
for larger tumors, especially those  10 cm in diameter.12 If any
suspicion of malignancy exists and laparoscopy is selected,
adnexectomy should be performed rather than tumorectomy.
Alternatively, laparotomy should be selected to minimize potential
cyst rupture.
In conclusion, this study found that appropriate postoperative
treatment resulted in a favorable prognosis for postoperatively
diagnosed borderline and malignant tumors in our hospital. Of
most importance is the accurate preoperative differentiation be-
tween benignancy and malignancy; however, in emergency cases
where themost reliablemodality cannot be used for evaluation due
to time constraints, it is important to keep inmind the possibility of
an occult malignancy and employ meticulous technique during
surgery to reduce the risk of cyst rupture.
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